ARDS logo

Aridis Pharmaceuticals (ARDS) EBITDA

Annual EBITDA

-$29.51 M
+$12.77 M+30.21%

December 31, 2022


Summary


Performance

ARDS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherARDSprofitabilitymetrics:

Quarterly EBITDA

-$869.00 K
-$14.60 M-106.33%

September 30, 2023


Summary


Performance

ARDS Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherARDSprofitabilitymetrics:

TTM EBITDA

-$633.00 K
+$6.42 M+91.02%

September 30, 2023


Summary


Performance

ARDS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherARDSprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

ARDS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+30.2%-106.3%+91.0%
3 y3 years-2.6%+84.8%+97.1%
5 y5 years-50.0%+88.1%+97.8%

ARDS EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+30.2%-106.3%+89.7%at high+98.6%
5 y5-year-33.7%+30.2%-106.3%+95.8%at high+98.6%
alltimeall time-275.4%+30.2%-106.3%+95.8%at high+98.6%

Aridis Pharmaceuticals EBITDA History

DateAnnualQuarterlyTTM
Sep 2023
-
-$869.00 K(-106.3%)
-$633.00 K(-91.0%)
Jun 2023
-
$13.73 M(-322.3%)
-$7.05 M(-75.2%)
Mar 2023
-
-$6.18 M(-15.6%)
-$28.39 M(-3.8%)
Dec 2022
-$29.51 M(-30.2%)
-$7.32 M(+0.5%)
-$29.51 M(-3.5%)
Sep 2022
-
-$7.29 M(-4.2%)
-$30.58 M(-30.9%)
Jun 2022
-
-$7.61 M(+4.3%)
-$44.23 M(+3.4%)
Mar 2022
-
-$7.29 M(-13.1%)
-$42.76 M(+1.1%)
Dec 2021
-$42.28 M(+91.6%)
-$8.39 M(-59.9%)
-$42.28 M(+6.7%)
Sep 2021
-
-$20.93 M(+240.9%)
-$39.62 M(+62.4%)
Jun 2021
-
-$6.14 M(-9.8%)
-$24.39 M(+8.9%)
Mar 2021
-
-$6.81 M(+18.6%)
-$22.40 M(+1.5%)
Dec 2020
-$22.06 M
-$5.74 M(+0.5%)
-$22.06 M(+0.6%)
Sep 2020
-
-$5.71 M(+37.6%)
-$21.93 M(-6.8%)
Jun 2020
-
-$4.15 M(-35.9%)
-$23.53 M(-14.6%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$6.47 M(+15.5%)
-$27.57 M(-4.1%)
Dec 2019
-$28.75 M(+20.6%)
-$5.60 M(-23.3%)
-$28.75 M(+0.4%)
Sep 2019
-
-$7.31 M(-10.7%)
-$28.64 M(+2.7%)
Jun 2019
-
-$8.18 M(+6.9%)
-$27.88 M(+15.3%)
Mar 2019
-
-$7.65 M(+39.3%)
-$24.17 M(+1.4%)
Dec 2018
-$23.83 M(+21.1%)
-$5.49 M(-16.0%)
-$23.83 M(+4.7%)
Sep 2018
-
-$6.54 M(+46.2%)
-$22.75 M(+4.9%)
Jun 2018
-
-$4.48 M(-38.8%)
-$21.68 M(+2.4%)
Mar 2018
-
-$7.32 M(+65.8%)
-$21.18 M(+7.6%)
Dec 2017
-$19.68 M(+150.3%)
-$4.42 M(-19.3%)
-$19.68 M(+28.9%)
Sep 2017
-
-$5.47 M(+37.8%)
-$15.26 M(+55.9%)
Jun 2017
-
-$3.97 M(-31.7%)
-$9.79 M(+68.3%)
Mar 2017
-
-$5.82 M
-$5.82 M
Dec 2016
-$7.86 M
-
-

FAQ

  • What is Aridis Pharmaceuticals annual EBITDA?
  • What is the all time high annual EBITDA for Aridis Pharmaceuticals?
  • What is Aridis Pharmaceuticals annual EBITDA year-on-year change?
  • What is Aridis Pharmaceuticals quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Aridis Pharmaceuticals?
  • What is Aridis Pharmaceuticals quarterly EBITDA year-on-year change?
  • What is Aridis Pharmaceuticals TTM EBITDA?
  • What is the all time high TTM EBITDA for Aridis Pharmaceuticals?
  • What is Aridis Pharmaceuticals TTM EBITDA year-on-year change?

What is Aridis Pharmaceuticals annual EBITDA?

The current annual EBITDA of ARDS is -$29.51 M

What is the all time high annual EBITDA for Aridis Pharmaceuticals?

Aridis Pharmaceuticals all-time high annual EBITDA is -$7.86 M

What is Aridis Pharmaceuticals annual EBITDA year-on-year change?

Over the past year, ARDS annual EBITDA has changed by +$12.77 M (+30.21%)

What is Aridis Pharmaceuticals quarterly EBITDA?

The current quarterly EBITDA of ARDS is -$869.00 K

What is the all time high quarterly EBITDA for Aridis Pharmaceuticals?

Aridis Pharmaceuticals all-time high quarterly EBITDA is $13.73 M

What is Aridis Pharmaceuticals quarterly EBITDA year-on-year change?

Over the past year, ARDS quarterly EBITDA has changed by -$14.60 M (-106.33%)

What is Aridis Pharmaceuticals TTM EBITDA?

The current TTM EBITDA of ARDS is -$633.00 K

What is the all time high TTM EBITDA for Aridis Pharmaceuticals?

Aridis Pharmaceuticals all-time high TTM EBITDA is -$633.00 K

What is Aridis Pharmaceuticals TTM EBITDA year-on-year change?

Over the past year, ARDS TTM EBITDA has changed by +$6.42 M (+91.02%)